Nonin Medical appoints new senior leadership

Nonin Medical, based in Minneapolis, made several changes to its senior leadership team as it makes plans to grow and expand.

The company, which designs and manufactures noninvasive medical monitoring devices, announced the changes last week in a statement.

Matthew Prior, who has worked at Nonin for more than eight years, has been promoted to vice president of business development. He was previously the company’s vice president of product development.

Greg Rausch replaced Prior as vice president of product development. Rausch has been with the company for more than six years and was previously Nonin’s director of advanced technology.

Lastly, Jill Wroblewski has been named senior director of marketing. She has been at Nonin for more than nine years and previously served as director of business development.

"Nonin Medical is committed to developing and promoting strong, agile, forward-thinking leaders who can grow the company in today's complex healthcare environment," said Phil Isaacson, CEO, chief technology officer and founder of Nonin Medical. "These leadership changes better position Nonin to more deeply understand customers' rapidly evolving clinical, practice and economic needs.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup